CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 89 filers reported holding CUREVAC N V in Q2 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,889 | +64716.7% | 924 | +0.1% | 0.00% | – |
| Q3 2023 | $6 | -40.0% | 923 | -1.7% | 0.00% | – |
| Q2 2023 | $10 | +66.7% | 939 | +1.1% | 0.00% | – |
| Q1 2023 | $6 | 0.0% | 929 | -2.3% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 951 | -11.4% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 1,073 | +11.3% | 0.00% | – |
| Q2 2022 | $13,000 | -27.8% | 964 | +6.2% | 0.00% | – |
| Q1 2022 | $18,000 | -83.5% | 908 | -71.5% | 0.00% | -100.0% |
| Q4 2021 | $109,000 | -12.8% | 3,181 | +38.9% | 0.00% | 0.0% |
| Q3 2021 | $125,000 | -37.8% | 2,290 | -16.3% | 0.00% | 0.0% |
| Q2 2021 | $201,000 | -37.0% | 2,735 | -21.6% | 0.00% | -50.0% |
| Q1 2021 | $319,000 | +9.2% | 3,490 | -3.1% | 0.00% | 0.0% |
| Q4 2020 | $292,000 | +84.8% | 3,602 | +5.9% | 0.00% | 0.0% |
| Q3 2020 | $158,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $230,000,000 | 35.34% |
| Affinity Asset Advisors, LLC | 150,000 | $11,022,000 | 3.95% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 132,300 | $9,722,000 | 0.79% |
| Renaissance Capital LLC | 56,915 | $4,182,000 | 0.66% |
| QCM Cayman, Ltd. | 2,744 | $202,000 | 0.52% |
| Green Alpha Advisors, LLC | 4,545 | $334,000 | 0.23% |
| Baillie Gifford | 5,515,262 | $405,261,000 | 0.20% |
| CSS LLC/IL | 60,000 | $4,408,000 | 0.18% |
| Caption Management, LLC | 161,400 | $11,860,000 | 0.16% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,484,000 | 0.15% |